Screener
Rigel Pharmaceuticals RIGL Q1 2026 earnings
Reported May 5, 2026 · After market close
Revenue$58.8MMiss by $3.6M
EPS$0.44Miss by $0.30
Revenue estimate$62.4M
EPS estimate$0.74
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$80.1M
EPS estimate$0.92
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Rigel Pharmaceuticals report Q1 2026 earnings?
- Rigel Pharmaceuticals (RIGL) reported Q1 2026 earnings on May 5, 2026 after market close.
- What were Rigel Pharmaceuticals's Q1 2026 revenue and EPS?
- Rigel Pharmaceuticals reported revenue of $58.8M and eps of $0.44 for Q1 2026.
- Did Rigel Pharmaceuticals beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $62.4M by $3.6M. EPS missed the consensus estimate of $0.74 by $0.30.
- How did Rigel Pharmaceuticals's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 10.3% from $53.3M a year earlier and eps declined 30.2% from $0.63.
- Where can I find Rigel Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001034842-26-000033) and the 10-Q periodic report (0001034842-26-000032) directly on SEC EDGAR. The filing index links above go to sec.gov.
